The most common bone stress injury in runners. PEMF accelerates periosteal healing — with return-to-training rates nearly twice those of rest-only protocols. Here is the clinical evidence and protocol.
May 2026 · 8 min read · Clinical Protocol
Medial Tibial Stress Syndrome (MTSS) — commonly called shin splints — is diffuse pain along the posteromedial border of the tibia triggered by repetitive mechanical loading. It occupies the mild end of the bone stress injury continuum: unresolved MTSS can progress through tibial stress reaction to frank stress fracture. MTSS accounts for 6–16% of all running injuries and affects up to 35% of military recruits during basic training — making it one of the highest-volume musculoskeletal conditions seen in sports medicine and military rehabilitation settings worldwide.
The standard protocol — rest, ice, load modification, and graduated return to activity — is safe but slow. Return to full training typically takes 4–8 weeks under a rest-only or conservative load-reduction approach, with a high recurrence rate if the underlying tibial cortical response has not fully resolved. NSAIDs may mask pain without addressing the bone remodeling deficit, and prolonged offloading carries its own deconditioning cost in competitive athletes and military personnel. Coaches and trainers increasingly demand a faster, evidence-based adjunct — which is exactly what PEMF provides.
PEMF directly targets the three biological processes driving MTSS chronicity:
PEMF's osteogenic effect has been documented across multiple tibial stress injury studies and validated by the broader bone healing literature (FDA 510(k) cleared for bone repair applications). Key findings:
| Parameter | PEMF | Rest + Ice | NSAIDs | Extracorporeal Shockwave |
|---|---|---|---|---|
| Avg. return to training | ~4.3 weeks | 4–8 weeks | Symptom masking only | 4–6 weeks |
| Addresses bone remodeling | Yes (osteogenic) | No | No | Yes (microtrauma-induced) |
| Pain during treatment | None | Minimal | None (oral) | Moderate to high |
| Adverse effects | None reported | Deconditioning | GI, renal, platelet effects | Bruising, temporary worsening |
| Recurrence at 6 months | 14% | 38% | N/A (not curative) | ~22% |
| FDA clearance | Yes (510k, bone repair) | N/A | Yes | Varies by indication |
MTSS patients of all activity levels — competitive runners, military personnel, and recreational athletes returning from deconditioning. No monitoring required during sessions. Contraindications are narrow: active cardiac pacemaker, pregnancy, active seizure disorder, or active malignancy in the treatment area. Metallic tibial fixation hardware is generally compatible at therapeutic PEMF intensities.
Sports medicine is a fast-growing segment in Philippine healthcare, driven by the running boom, military rehabilitation demand, and an increasingly active urban population. MTSS patients are ideal clinic clients: young, motivated, compliant, and committed to a full treatment course of 8–16 sessions. The ability to offer a documented, non-pharmacological accelerated recovery pathway differentiates a PEMF-equipped clinic from a standard physiotherapy practice and supports premium session pricing of ₱1,500–₱2,500. The 70+ Israeli clinics (population: 9M) already running this protocol — now expanding to the Philippines — validate the commercial model.
Request the full investor package — including clinic revenue modeling and setup costs for the Philippines market.
Request Investment Brief →